0001358403-14-000002.txt : 20140903
0001358403-14-000002.hdr.sgml : 20140903
20140903154646
ACCESSION NUMBER: 0001358403-14-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20140903
DATE AS OF CHANGE: 20140903
EFFECTIVENESS DATE: 20140903
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0001358403
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-224038
FILM NUMBER: 141080482
BUSINESS ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 850
CITY: HOUSTON
STATE: TX
ZIP: 77030
BUSINESS PHONE: (832) 384-1100
MAIL ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 850
CITY: HOUSTON
STATE: TX
ZIP: 77030
FORMER COMPANY:
FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060405
D
1
primary_doc.xml
X0707
D
LIVE
0001358403
BELLICUM PHARMACEUTICALS, INC
2130 West Holcombe Boulevard
Suite 850
HOUSTON
TX
TEXAS
77030
(832) 384-1100
DELAWARE
BELLICUM PHARMACEUTICALS INC
Corporation
true
Thomas
J.
Farrell
2130 West Holcombe Boulevard
Suite 850
Houston
TX
TEXAS
77030
Executive Officer
Director
Kevin
M.
Slawin
2130 West Holcombe Boulevard
Suite 850
Houston
TX
TEXAS
77030
Director
Frank
McGuyer
2130 West Holcombe Boulevard
Suite 850
Houston
TX
TEXAS
77030
Director
James
F.
Brown
2130 West Holcombe Boulevard
Suite 850
Houston
TX
TEXAS
77030
Director
David
M.
Spencer
2130 West Holcombe Boulevard
Suite 850
Houston
TX
TEXAS
77030
Executive Officer
Dennis
K.
Stone
2130 West Holcombe Boulevard
Suite 850
Houston
TX
TEXAS
77030
Director
Annemarie
Moseley
2130 West Holcombe Boulevard
Suite 850
Houston
TX
TEXAS
77030
Executive Officer
Ken
Moseley
2130 West Holcombe Boulevard
Suite 850
Houston
TX
TEXAS
77030
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2014-08-22
false
true
true
true
false
0
Jefferies LLC
2347
None
None
520 Madison Avenue, 2nd Floor
New York
NY
NEW YORK
10022
CA
CALIFORNIA
CO
COLORADO
MD
MARYLAND
MA
MASSACHUSETTS
NJ
NEW JERSEY
NY
NEW YORK
false
94357588
94357588
0
The Total Offering Amount and Total Amount Sold includes $39,357,588 that may be received by the Issuer upon exercise of the warrants.
false
76
3141250
0
0
false
BELLICUM PHARMACEUTICALS, INC
/s/ Thomas J. Farrell
Thomas J. Farrell
President & CEO
2014-09-02